Jane Street Group LLC purchased a new position in shares of Ardent Health Partners, LLC (NYSE:ARDT – Free Report) in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund purchased 30,829 shares of the company’s stock, valued at approximately $567,000.
Several other hedge funds have also recently added to or reduced their stakes in ARDT. BNP Paribas Financial Markets bought a new stake in Ardent Health Partners during the third quarter worth about $42,000. Financial Management Professionals Inc. bought a new stake in shares of Ardent Health Partners in the 3rd quarter valued at about $50,000. MetLife Investment Management LLC bought a new stake in shares of Ardent Health Partners in the 3rd quarter valued at about $135,000. Quadrature Capital Ltd bought a new stake in shares of Ardent Health Partners in the 3rd quarter valued at about $229,000. Finally, Centiva Capital LP bought a new stake in shares of Ardent Health Partners in the 3rd quarter valued at about $469,000.
Analyst Ratings Changes
A number of equities research analysts have recently weighed in on the company. JPMorgan Chase & Co. reissued a “neutral” rating and issued a $20.00 target price on shares of Ardent Health Partners in a research note on Tuesday, December 17th. Royal Bank of Canada reissued an “outperform” rating and issued a $23.00 target price on shares of Ardent Health Partners in a research note on Thursday, November 14th. Leerink Partners boosted their target price on Ardent Health Partners from $23.00 to $25.00 and gave the company an “outperform” rating in a research note on Tuesday, November 12th. Bank of America lowered Ardent Health Partners from a “buy” rating to a “neutral” rating and lowered their target price for the company from $22.00 to $19.00 in a research note on Wednesday, November 6th. Finally, KeyCorp assumed coverage on Ardent Health Partners in a report on Friday, October 11th. They set an “overweight” rating and a $24.00 price target on the stock. Two investment analysts have rated the stock with a hold rating, eight have assigned a buy rating and two have issued a strong buy rating to the company’s stock. Based on data from MarketBeat.com, Ardent Health Partners currently has an average rating of “Buy” and a consensus price target of $22.00.
Ardent Health Partners Price Performance
Shares of NYSE:ARDT opened at $16.64 on Monday. Ardent Health Partners, LLC has a 52-week low of $14.57 and a 52-week high of $20.72. The stock has a 50 day moving average price of $16.75. The company has a debt-to-equity ratio of 0.78, a current ratio of 1.91 and a quick ratio of 1.78.
Ardent Health Partners Profile
Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.
See Also
- Five stocks we like better than Ardent Health Partners
- Why is the Ex-Dividend Date Significant to Investors?
- Cold Front, Hot Stocks: Diesel Prices Propel Energy Leaders
- 3 Natural Gas Stocks That Offer Great Dividend Yields
- Sustainable and Successful: 3 Climate ETFs Beating the Market
- How Can Investors Benefit From After-Hours Trading
- Quantum Opportunity: Skywater Technology’s Long-Term Potential
Receive News & Ratings for Ardent Health Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ardent Health Partners and related companies with MarketBeat.com's FREE daily email newsletter.
